Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Latanoprost 50micrograms/ml eye drops
1106000L0AAAAAA
|
Latanoprost | Latanoprost | Eye | 414,308 |
|
Latanoprost 50micrograms/ml eye dps 0.2ml ud preserv free
1106000L0AAABAB
|
Latanoprost | Latanoprost | Eye | 132,172 |
|
Monopost 50micrograms/ml eye drops 0.2ml unit dose
1106000L0BCAAAB
|
Monopost | Latanoprost | Eye | 122,412 |
|
Xalatan 50micrograms/ml eye drops
1106000L0BBAAAA
|
Xalatan | Latanoprost | Eye | 16,132 |
|
Latanoprost 50micrograms/ml eye drops preservative free
1106000L0AAACAC
|
Latanoprost | Latanoprost | Eye | 3,637 |
|
Lotacryn 50micrograms/ml eye drops
1106000L0BEAAAC
|
Lotacryn | Latanoprost | Eye | 259 |
|
Medizol 0.005% eye drops
1106000L0BDAAAA
|
Medizol | Latanoprost | Eye | 11 |
|
Catiolanze 50micrograms/ml eye dps emulsn 0.3ml unit dose
1106000L0BFAAAD
|
Catiolanze | Latanoprost | Eye | No data available |
|
Latanoprost 50micrograms/ml eye dps 0.3ml ud preserv free
1106000L0AAADAD
|
Latanoprost | Latanoprost | Eye | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.